- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hodgkin Disease in New Zealand
Total 43880 results
-
Weill Medical College of Cornell UniversityCompletedHodgkins Disease | Lymphoma, Non-HodgkinsUnited States
-
Columbia UniversityCompletedNon-Hodgkin's Lymphoma | Hodgkins DiseaseUnited States
-
Malaghan Institute of Medical ResearchWellington Zhaotai Therapies Limited (WZTL)RecruitingMantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Lymphomas Non-Hodgkin's B-Cell | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL)New Zealand
-
Peter MacCallum Cancer Centre, AustraliaActive, not recruitingHodgkin LymphomaAustralia, New Zealand
-
Weill Medical College of Cornell UniversityCompletedHodgkin's Lymphoma | Non-Hodgkin's LymphomaUnited States
-
CytokineticsCompletedNon-Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States, Russian Federation
-
Columbia UniversityMerck Sharp & Dohme LLCCompletedNon-Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States
-
Cortice Biosciences, Inc.CompletedNeoplasms | Hodgkin Disease | Non-Hodgkin LymphomaUnited States
-
Columbia UniversityTerminatedHodgkin Disease | Lymphoma, Non-hodgkinUnited States
-
Divaya BhutaniGenzyme, a Sanofi CompanyRecruitingIsatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and LymphomaLymphoma | Multiple Myeloma | Non-Hodgkin Lymphoma | Relapsed Hodgkin's Disease, AdultUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-Hodgkin Lymphoma | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma RefractoryUnited States
-
Columbia UniversityCelgeneTerminatedLymphoma | Hodgkin Lymphoma | Lymphoid Malignancies | Non-hodgkin LymphomaUnited States
-
Montefiore Medical CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterCephalonCompletedLymphoma | Hodgkin's DiseaseUnited States
-
Roswell Park Cancer InstituteNovartisTerminatedHodgkin's Lymphoma | Non-Hodgkin's LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterSeagen Inc.; Hôpitaux Universitaires Henri Mondor, FranceCompletedHodgkin's LymphomaUnited States
-
Weill Medical College of Cornell UniversityTerminatedHodgkin's LymphomaUnited States
-
University of RochesterCompletedLymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States
-
Hoffmann-La RocheRecruitingNon-Hodgkin's LymphomaBelgium, Australia, Denmark, Spain, Taiwan, France, Italy, United States, Canada, Czechia, New Zealand, Poland, Finland
-
TanoxUnknownHodgkin's LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage III Non-Hodgkin Lymphoma | Ann Arbor Stage IV Non-Hodgkin Lymphoma | Solid NeoplasmUnited States
-
Genzyme, a Sanofi CompanyTerminatedNon-Hodgkins LymphomaUnited States
-
Celgene CorporationPrologue Research InternationalCompletedNon-Hodgkins LymphomaUnited States, Canada
-
University of ChicagoActive, not recruitingCLL | B-cell Non Hodgkin LymphomaUnited States
-
Celgene CorporationPrologue Research InternationalCompletedNon-Hodgkins LymphomaUnited States
-
GPCR Therapeutics, Inc.CompletedMultiple Myeloma | Hodgkin Disease | Non-Hodgkin LymphomaUnited States
-
SanofiCompletedLymphoma | Non-HodgkinUnited States
-
Novartis PharmaceuticalsCompletedHodgkin's LymphomaUnited States, Belgium, Germany, Canada, Singapore, Netherlands, France, Australia, Russian Federation, Israel, Brazil, Italy, New Zealand, Poland
-
GPCR Therapeutics, Inc.CompletedMultiple Myeloma | Non-hodgkin's Lymphoma | Hodgkin's DiseaseUnited States
-
Innate PharmaRecruitingNon Hodgkin LymphomaUnited States, Australia
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; Queen's University, Kingston,...CompletedLeukemia | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Myelodysplastic SyndromeUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | B-cell Non-Hodgkin's LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
SIRPant Immunotherapeutics, Inc.RecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
American Scitech InternationalBristol-Myers Squibb; Eli Lilly and CompanyUnknownHodgkin's LymphomaUnited States
-
National Cancer Institute (NCI)Completed
-
Chiron CorporationTerminatedNon-Hodgkin LymphomaUnited States
-
ADC Therapeutics S.A.CompletedHodgkin Lymphoma | Non-Hodgkin LymphomaUnited States, United Kingdom
-
New York Medical CollegeJohns Hopkins University; M.D. Anderson Cancer Center; Baylor College of Medicine and other collaboratorsCompletedNon-Hodgkins Lymphoma | Lymphoproliferative Disorder | Hodgkins LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; University of Washington; H. Lee...Active, not recruiting
-
University of CologneEli Lilly and Company; German Hodgkin's Lymphoma Study GroupCompleted
-
University of CologneJohnson & Johnson Pharmaceutical Research & Development, L.L.C.; German Hodgkin...Terminated
-
Bayside HealthCompletedNon-Hodgkin's Lymphoma | Hodgkin's DiseaseAustralia
-
Novartis PharmaceuticalsCompletedClassical Hodgkin's LymphomaSpain, France, Belgium, Italy, Israel, Germany, United States, Australia, Brazil, Singapore, Malaysia, New Zealand, United Kingdom
-
PfizerCompletedHodgkin Disease | Thrombocytopenia | Non-Hodgkin LymphomaUnited States, Russian Federation, Singapore, Australia, France, Hong Kong, Greece, Poland
-
Washington University School of MedicineCelgene CorporationCompleted
-
Bristol-Myers SquibbCompletedHodgkin's LymphomasUnited States
-
Syndax PharmaceuticalsTerminatedHodgkin's LymphomaUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisNew Zealand, Australia
-
AbbottCompletedLymphoma, Non-Hodgkin | Hodgkin's LymphomaUnited States